{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:14:04Z","timestamp":1788297244295,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000883","name":"University of Bristol","doi-asserted-by":"publisher","award":["MR\/L022206\/1"],"award-info":[{"award-number":["MR\/L022206\/1"]}],"id":[{"id":"10.13039\/501100000883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003245","name":"Ministerie van Onderwijs, Cultuur en Wetenschap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["875534"],"award-info":[{"award-number":["875534"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["217065\/Z\/19\/Z"],"award-info":[{"award-number":["217065\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["4.1.13.007"],"award-info":[{"award-number":["4.1.13.007"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["184.021.007"],"award-info":[{"award-number":["184.021.007"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["184033111"],"award-info":[{"award-number":["184033111"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001828","name":"Erasmus Universiteit Rotterdam","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001828","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003061","name":"Erasmus Medisch Centrum","doi-asserted-by":"publisher","award":["EMCF20213"],"award-info":[{"award-number":["EMCF20213"]}],"id":[{"id":"10.13039\/501100003061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL061019"],"award-info":[{"award-number":["R01 HL061019"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL060894"],"award-info":[{"award-number":["R01 HL060894"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL061210"],"award-info":[{"award-number":["R01 HL061210"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL060919"],"award-info":[{"award-number":["R01 HL060919"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL060944"],"award-info":[{"award-number":["R01 HL060944"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK118062"],"award-info":[{"award-number":["DK118062"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK085175"],"award-info":[{"award-number":["DK085175"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.gastha.2024.09.006","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T21:33:27Z","timestamp":1726176807000},"page":"100551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Plasma Circulating Metabolites Associated With Steatotic Liver Disease and Liver Enzymes: A Multiplatform Population-Based Study"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3720-5205","authenticated-orcid":false,"given":"Yasir J.","family":"Abozaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Ayada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurens A.","family":"van Kleef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"Goulding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica S.","family":"Williams-Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"de Knegt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne E.","family":"Wagenknecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholette D.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Timpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yii-Der","family":"Ida Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Arfan","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem Pieter","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9476-7143","authenticated-orcid":false,"given":"Mohsen","family":"Ghanbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.gastha.2024.09.006_bib1","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.3748\/wjg.v22.i16.4079","article-title":"Nonalcoholic fatty liver disease as a multi-systemic disease","volume":"22","author":"Fotbolcu","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.gastha.2024.09.006_bib2","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2024.09.006_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.603926","article-title":"Non-alcoholic steatohepatitis: a review of its mechanism, models and medical treatments","volume":"11","author":"Peng","year":"2020","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.gastha.2024.09.006_bib4","article-title":"NAFLD and liver transplantation: disease burden, current management and future challenges","volume":"2","author":"Burra","year":"2020","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.gastha.2024.09.006_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.gastha.2024.09.006_bib6","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"18","key":"10.1016\/j.gastha.2024.09.006_bib7","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1042\/CS20220572","article-title":"Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways","volume":"136","author":"Badmus","year":"2022","journal-title":"Clin Sci"},{"issue":"6","key":"10.1016\/j.gastha.2024.09.006_bib8","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/hep.23593","article-title":"Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study","volume":"51","author":"Speliotes","year":"2010","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.gastha.2024.09.006_bib9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.7326\/0003-4819-143-10-200511150-00009","article-title":"The metabolic syndrome as a predictor of nonalcoholic fatty liver disease","volume":"143","author":"Hamaguchi","year":"2005","journal-title":"Ann Intern Med"},{"issue":"6037","key":"10.1016\/j.gastha.2024.09.006_bib10","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.gastha.2024.09.006_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/07853890.2014.966752","article-title":"Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study","volume":"47","author":"Suomela","year":"2015","journal-title":"Ann Med"},{"issue":"12","key":"10.1016\/j.gastha.2024.09.006_bib12","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1038\/s41591-024-02958-z","article-title":"Opportunities and challenges following approval of resmetirom for MASH liver disease","volume":"30","author":"Lazarus","year":"2024","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.gastha.2024.09.006_bib13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1445-5994.2006.01210.x","article-title":"Liver biopsy: is it still relevant?","volume":"36","author":"Shackel","year":"2006","journal-title":"Intern Med J"},{"key":"10.1016\/j.gastha.2024.09.006_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.03.008","article-title":"Liquid biopsy in chronic liver disease","volume":"20","author":"Barrera-Saldana","year":"2021","journal-title":"Ann Hepatol"},{"issue":"10","key":"10.1016\/j.gastha.2024.09.006_bib15","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.cgh.2016.05.046","article-title":"Noninvasive detection of nonalcoholic steatohepatitis using clinical markers and circulating levels of lipids and metabolites","volume":"14","author":"Zhou","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.gastha.2024.09.006_bib16","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","article-title":"Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease","volume":"64","author":"Luukkonen","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.gastha.2024.09.006_bib17","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.14309\/ajg.0000000000000661","article-title":"Allogenic fecal microbiota transplantation in patients with nonalcoholic fatty liver disease improves abnormal small intestinal permeability: a randomized control trial","volume":"115","author":"Craven","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gastha.2024.09.006_bib18","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep.31417","article-title":"Microbiomics, metabolomics, predicted Metagenomics, and hepatic steatosis in a population-based study of 1,355 adults","volume":"73","author":"Alferink","year":"2021","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.gastha.2024.09.006_bib19","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/ajcn\/nqab392","article-title":"Adiposity, metabolomic biomarkers, and risk of nonalcoholic fatty liver disease: a case-cohort study","volume":"115","author":"Pang","year":"2022","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.gastha.2024.09.006_bib20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1194\/jlr.P056002","article-title":"Biomarkers of NAFLD progression: a lipidomics approach to an epidemic","volume":"56","author":"Gorden","year":"2015","journal-title":"J\u00a0Lipid Res"},{"issue":"2","key":"10.1016\/j.gastha.2024.09.006_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10654-023-01094-1","article-title":"The Rotterdam Study. Design update and major findings between 2020 and 2024","volume":"39","author":"Ikram","year":"2024","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"10.1016\/j.gastha.2024.09.006_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ije\/dys064","article-title":"Cohort profile: the \u2018children of the 90s\u2019\u2014the index offspring of the Avon longitudinal study of parents and children","volume":"42","author":"Boyd","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.gastha.2024.09.006_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ije\/dys066","article-title":"Cohort profile: the Avon longitudinal study of parents and children: ALSPAC mothers cohort","volume":"42","author":"Fraser","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.gastha.2024.09.006_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.12688\/wellcomeopenres.15132.1","article-title":"The Avon Longitudinal Study of Parents and Children (ALSPAC): an update on the enrolled sample of index children in 2019","volume":"4","author":"Northstone","year":"2019","journal-title":"Wellcome Open Res"},{"issue":"4","key":"10.1016\/j.gastha.2024.09.006_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1047-2797(02)00412-X","article-title":"Genetic epidemiology of insulin resistance and visceral adiposity: the IRAS Family Study design and methods","volume":"13","author":"Henkin","year":"2003","journal-title":"Ann Epidemiol"},{"issue":"1","key":"10.1016\/j.gastha.2024.09.006_bib26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/CIRCGENETICS.114.000216","article-title":"Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics","volume":"8","author":"Soininen","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"10.1016\/j.gastha.2024.09.006_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms11122","article-title":"Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA","volume":"7","author":"Kettunen","year":"2016","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.gastha.2024.09.006_bib28","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1039\/b910205a","article-title":"High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism","volume":"134","author":"Soininen","year":"2009","journal-title":"Analyst"},{"issue":"12","key":"10.1016\/j.gastha.2024.09.006_bib29","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","article-title":"The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation","volume":"102","author":"Hamaguchi","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gastha.2024.09.006_bib30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.atherosclerosis.2006.07.007","article-title":"Association between calcification in the coronary arteries, aortic arch and carotid arteries: the Rotterdam study","volume":"193","author":"Odink","year":"2007","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.gastha.2024.09.006_bib31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jhep.2016.04.023","article-title":"Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease","volume":"65","author":"Boursier","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.gastha.2024.09.006_bib32","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/gut.2010.221382","article-title":"Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years","volume":"60","author":"Roulot","year":"2011","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.gastha.2024.09.006_bib33","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/liv.12226","article-title":"Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)","volume":"33","author":"Verma","year":"2013","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.gastha.2024.09.006_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/liv.12311","article-title":"Serum liver enzymes are associated with all-cause mortality in an elderly population","volume":"34","author":"Koehler","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.gastha.2024.09.006_bib35","series-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO\/IDF consultation","year":"2006"},{"issue":"17","key":"10.1016\/j.gastha.2024.09.006_bib36","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","article-title":"METAL: fast and efficient meta-analysis of genomewide association scans","volume":"26","author":"Willer","year":"2010","journal-title":"Bioinformatics"},{"issue":"7414","key":"10.1016\/j.gastha.2024.09.006_bib37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.gastha.2024.09.006_bib38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/hep.28899","article-title":"Metabolic profiling of fatty liver in young and middle-aged adults: cross-sectional and prospective analyses of the Young Finns Study","volume":"65","author":"Kaikkonen","year":"2017","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.gastha.2024.09.006_bib39","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2024.09.006_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metabol"},{"issue":"5","key":"10.1016\/j.gastha.2024.09.006_bib41","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3892\/br.2014.309","article-title":"Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes","volume":"2","author":"Tomizawa","year":"2014","journal-title":"Biomed Rep"},{"key":"10.1016\/j.gastha.2024.09.006_bib42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.12688\/wellcomeopenres.14974.1","article-title":"Metabolic profiling of adolescent non-alcoholic fatty liver disease","volume":"3","author":"Hartley","year":"2018","journal-title":"Wellcome Open Res"},{"issue":"3","key":"10.1016\/j.gastha.2024.09.006_bib43","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/ajcn\/nqac150","article-title":"Associations of serum n\u20133 and n\u20136 polyunsaturated fatty acids with prevalence and incidence of nonalcoholic fatty liver disease","volume":"116","author":"M\u00e4kel\u00e4","year":"2022","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.gastha.2024.09.006_bib44","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.metabol.2016.01.011","article-title":"Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity","volume":"65","author":"Walle","year":"2016","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.gastha.2024.09.006_bib45","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1210\/clinem\/dgaa693","article-title":"The plasma metabolomic profile is differently associated with liver fat, visceral adipose tissue, and pancreatic fat","volume":"106","author":"Lind","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.gastha.2024.09.006_bib46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hep.29465","article-title":"Altered amino acid concentrations in NAFLD: impact of obesity and insulin resistance","volume":"67","author":"Gaggini","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gastha.2024.09.006_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-31865-w","article-title":"Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome","volume":"8","author":"Lovric","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.gastha.2024.09.006_bib48","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3390\/biomedicines10061444","article-title":"The emerging role of branched-chain amino acids in liver diseases","volume":"10","author":"Lo","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.gastha.2024.09.006_bib49","first-page":"765","article-title":"Metabolic alterations associated with early-stage hepatocellular carcinoma and their correlation with aging and enzymatic activity in patients with viral hepatitis-induced liver cirrhosis: a preliminary study","volume":"9","author":"Moon","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.gastha.2024.09.006_bib50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/bs.acr.2018.05.002","article-title":"Sphingolipids at the crossroads of NAFLD and senescence","volume":"140","author":"Nikolova-Karakashian","year":"2018","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.gastha.2024.09.006_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biochi.2018.07.021","article-title":"Sphingolipid metabolism in non-alcoholic fatty liver diseases","volume":"159","author":"R\u00e9gnier","year":"2019","journal-title":"Biochimie"},{"issue":"7","key":"10.1016\/j.gastha.2024.09.006_bib52","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/nu9070642","article-title":"A\u00a0branched-chain amino acid-related metabolic signature characterizes obese adolescents with non-alcoholic fatty liver disease","volume":"9","author":"Goffredo","year":"2017","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.gastha.2024.09.006_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104513","article-title":"Genome-scale metabolic modelling of the human gut microbiome reveals changes in the glyoxylate and dicarboxylate metabolism in metabolic disorders","volume":"25","author":"Proffitt","year":"2022","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.gastha.2024.09.006_bib54","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1210\/jc.2006-0075","article-title":"Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study","volume":"91","author":"Chalasani","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.gastha.2024.09.006_bib55","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00216-006-0687-8","article-title":"Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics","volume":"387","author":"Pan","year":"2007","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.gastha.2024.09.006_bib56","article-title":"A\u00a0reappraisal of the diagnostic performance of B-mode ultrasonography for mild liver steatosis","volume":"10","author":"Lee","year":"2022","journal-title":"Am J Gastroenterol"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572324001456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572324001456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:05:06Z","timestamp":1778933106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572324001456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"alternative-id":["S2772572324001456"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2024.09.006","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma Circulating Metabolites Associated With Steatotic Liver Disease and Liver Enzymes: A Multiplatform Population-Based Study","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2024.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}],"article-number":"100551"}}